Sufficient α1-antitrypsin is generated by wild-type cells to suppress ERK1/2 and NF-κB signalling, but this anti-inflammatory effect appears to be lost in ZZ epithelia, suggesting a novel mechanism for airway pathology in α1-antitrypsin deficiency. The gene discussed is MAPK3; the disease is hyperinsulinemic hypoglycemia, familial, 4.